HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

fructofuranosyl-(2-2)-fructofuranosyl

a neuroprotective agent; isolated from Morinda officinalis; structure in first source

Also Known As:

bajijiasu

Networked: 7 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Disaccharides: 990
      - fructofuranosyl-(2-2)-fructofuranosyl: 7
- Sugars: 11126
  - Disaccharides: 990
    - fructofuranosyl-(2-2)-fructofuranosyl: 7

Experts

1.	Lin, Li: 6 articles (01/2018 - 08/2013)
2.	Fang, Jiansong: 3 articles (01/2018 - 11/2017)
3.	Guan, Li: 3 articles (01/2018 - 11/2017)
4.	Wang, Qi: 3 articles (01/2018 - 11/2017)
5.	Wu, Jun: 3 articles (01/2018 - 11/2017)
6.	Cai, Haobin: 2 articles (01/2018 - 11/2017)
7.	Cai, Tiantian: 2 articles (01/2018 - 11/2017)
8.	Guo, Zhouke: 2 articles (01/2018 - 11/2017)
9.	He, Jiayang: 2 articles (01/2018 - 11/2017)
10.	Pan, Huafeng: 2 articles (01/2018 - 11/2017)

Related Diseases

1.	Alzheimer Disease (Alzheimer's Disease) 01/01/2018 - "Bajijiasu Ameliorates β-Amyloid-Triggered Endoplasmic Reticulum Stress and Related Pathologies in an Alzheimer's Disease Model."
2.	Pheochromocytoma 08/01/2013 - "This study evaluated the protective effect of Bajijiasu (β- D-fructofuranosyl (2-2) β- D-fructofuranosyl), a dimeric fructose isolated from the Chinese herb Radix Morinda officinalis, on Aβ-induced neurotoxicity in pheochromocytoma (PC12) cells. "
3.	Ischemia 05/28/2014 - "Previous studies have shown that bajijiasu, a dimeric fructose isolated from Morinda officinalis radix which was used frequently as a tonifying and replenishing natural herb medicine in traditional Chinese medicine clinic practice, can prevent ischemia-induced neuronal damage or death. "
4.	Bone Resorption 01/19/2017 - "In the present study, we found that Bajijiasu dose-dependently inhibited RANKL-induced osteoclast formation and bone resorption from 0.1 mM, and reached half maximal inhibitory effects (IC50) at 0.4 mM without toxicity. " 01/19/2017 - "Taken together, this study revealed Bajijiasu could attenuate osteoclast formation and bone resorption by mediating RANKL signaling pathways, indicative of a potential effect of Bajijiasu on osteolytic bone diseases."
5.	Bone Diseases (Bone Disease) 01/19/2017 - "Taken together, this study revealed Bajijiasu could attenuate osteoclast formation and bone resorption by mediating RANKL signaling pathways, indicative of a potential effect of Bajijiasu on osteolytic bone diseases."

Related Drugs and Biologics

1.	Amyloid (Amyloid Fibrils)
2.	Fructose
3.	Neuroprotective Agents

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)